Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View item
  • Home
  • ICR Divisions
  • Radiotherapy and Imaging
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up.

Thumbnail
View/Open
Accepted version (942.7Kb)
Date
2018-08
ICR Author
Huddart, Robert
Author
Honecker, F
Aparicio, J
Berney, D
Beyer, J
Bokemeyer, C
Cathomas, R
Clarke, N
Cohn-Cedermark, G
Daugaard, G
Dieckmann, K-P
Fizazi, K
Fosså, S
Germa-Lluch, JR
Giannatempo, P
Gietema, JA
Gillessen, S
Haugnes, HS
Heidenreich, A
Hemminki, K
Huddart, R
Jewett, MAS
Joly, F
Lauritsen, J
Lorch, A
Necchi, A
Nicolai, N
Oing, C
Oldenburg, J
Ondruš, D
Papachristofilou, A
Powles, T
Sohaib, A
Ståhl, O
Tandstad, T
Toner, G
Horwich, A
Show allShow less
Type
Journal Article
Metadata
Show full item record
Abstract
The European Society for Medical Oncology (ESMO) consensus conference on testicular cancer was held on 3-5 November 2016 in Paris, France. The conference included a multidisciplinary panel of 36 leading experts in the diagnosis and treatment of testicular cancer (34 panel members attended the conference; an additional two panel members [CB and K-PD] participated in all preparatory work and subsequent manuscript development). The aim of the conference was to develop detailed recommendations on topics relating to testicular cancer that are not covered in detail in the current ESMO Clinical Practice Guidelines (CPGs) and where the available level of evidence is insufficient. The main topics identified for discussion related to: (1) diagnostic work-up and patient assessment; (2) stage I disease; (3) stage II-III disease; (4) post-chemotherapy surgery, salvage chemotherapy, salvage and desperation surgery and special topics; and (5) survivorship and follow-up schemes. The experts addressed questions relating to one of the five topics within five working groups. Relevant scientific literature was reviewed in advance. Recommendations were developed by the working groups and then presented to the entire panel. A consensus vote was obtained following whole-panel discussions, and the consensus recommendations were then further developed in post-meeting discussions in written form. This manuscript presents the results of the expert panel discussions, including the consensus recommendations and a summary of evidence supporting each recommendation. All participants approved the final manuscript.
URI
https://repository.icr.ac.uk/handle/internal/3316
DOI
https://doi.org/10.1093/annonc/mdy217
Collections
  • Radiotherapy and Imaging
Subject
Testis
Humans
Neoplasms, Germ Cell and Embryonal
Testicular Neoplasms
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Neoadjuvant Therapy
Salvage Therapy
Aftercare
Palliative Care
Orchiectomy
Risk Factors
Medical Oncology
Quality of Life
Societies, Medical
Europe
Male
Consensus Development Conferences as Topic
Practice Guidelines as Topic
Chemoradiotherapy, Adjuvant
Cancer Survivors
Survivorship
Research team
Clinical Academic Radiotherapy (Huddart)
Language
eng
License start date
2018-08
Citation
Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 29 (8), pp. 1658 - 1686

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.